PDCD1 and neoplasm: Moreover, PD-L1 can be significantly upregulated after radiotherapy in HPV-associated OPC to antagonize anti-tumor activity, which can be reversed by anti-PD-1 or anti-PD-L1 antibodies [61] (Figure 2).